These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 29981179
1. Transplantation in foreign nationals: Lower rates of waitlist mortality and higher rates of lost to follow-up posttransplant. Ferrante ND, Goldberg DS. Am J Transplant; 2018 Nov; 18(11):2663-2669. PubMed ID: 29981179 [Abstract] [Full Text] [Related]
2. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death. Valentino PL, Emre S, Geliang G, Li L, Deng Y, Mulligan D, Rodriguez-Davalos MI. Am J Transplant; 2019 Nov; 19(11):3114-3123. PubMed ID: 31152483 [Abstract] [Full Text] [Related]
3. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates. Braun HJ, Perito ER, Dodge JL, Rhee S, Roberts JP. Am J Transplant; 2016 Nov; 16(11):3181-3191. PubMed ID: 27214757 [Abstract] [Full Text] [Related]
4. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates. Perito ER, Bucuvalas J, Lai JC. Am J Transplant; 2019 May; 19(5):1388-1396. PubMed ID: 30506640 [Abstract] [Full Text] [Related]
5. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, O'Mahony CA, Goss JA, Rana A. Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020 [Abstract] [Full Text] [Related]
6. Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics. Thuluvath PJ, Amjad W, Zhang T. PLoS One; 2020 Dec; 15(12):e0244744. PubMed ID: 33382811 [Abstract] [Full Text] [Related]
7. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Kwong AJ, Lai JC, Dodge JL, Roberts JP. Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624 [Abstract] [Full Text] [Related]
8. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates. Swenson SM, Roberts JP, Rhee S, Perito ER. Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108 [Abstract] [Full Text] [Related]
9. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores. Croome KP, Lee DD, Nguyen JH, Keaveny AP, Taner CB. Am J Transplant; 2017 Sep; 17(9):2420-2427. PubMed ID: 28556380 [Abstract] [Full Text] [Related]
10. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients. Ross K, Patzer RE, Goldberg DS, Lynch RJ. Am J Transplant; 2017 Nov; 17(11):2879-2889. PubMed ID: 28695615 [Abstract] [Full Text] [Related]
11. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation. McCabe P, Wong RJ. Clin Transplant; 2018 Sep; 32(9):e13346. PubMed ID: 29979466 [Abstract] [Full Text] [Related]
12. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE. Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284 [Abstract] [Full Text] [Related]
13. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700 [Abstract] [Full Text] [Related]
14. Functional status, healthcare utilization, and the costs of liver transplantation. Serper M, Bittermann T, Rossi M, Goldberg DS, Thomasson AM, Olthoff KM, Shaked A. Am J Transplant; 2018 May; 18(5):1187-1196. PubMed ID: 29116679 [Abstract] [Full Text] [Related]
15. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079 [Abstract] [Full Text] [Related]
16. Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends. Kaur N, Emamaullee J, Lian T, Lo M, Ender P, Kahn J, Sher L. Transplantation; 2021 May 01; 105(5):1052-1060. PubMed ID: 33741845 [Abstract] [Full Text] [Related]
17. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change. Ishaque T, Massie AB, Bowring MG, Haugen CE, Ruck JM, Halpern SE, Waldram MM, Henderson ML, Garonzik Wang JM, Cameron AM, Philosophe B, Ottmann S, Rositch AF, Segev DL. Am J Transplant; 2019 Feb 01; 19(2):564-572. PubMed ID: 30312530 [Abstract] [Full Text] [Related]
18. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data. Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP. Am J Transplant; 2017 Sep 01; 17(9):2410-2419. PubMed ID: 28226199 [Abstract] [Full Text] [Related]
19. Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death. Miyake K, Chau LC, Trudeau S, Kitajima T, Wickramaratne N, Shimada S, Nassar A, Gonzalez HC, Venkat D, Moonka D, Yoshida A, Abouljoud MS, Nagai S. Transplantation; 2024 Sep 01; 108(9):1943-1953. PubMed ID: 38409687 [Abstract] [Full Text] [Related]
20. Improved posttransplant mortality after share 35 for liver transplantation. Kwong AJ, Goel A, Mannalithara A, Kim WR. Hepatology; 2018 Jan 01; 67(1):273-281. PubMed ID: 28586179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]